Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 20, Issue 22, 2014, Pages 6821-6825

  Khov, Nancy ^a   Sharma, Amol ^a   Riley, Thomas R ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bedside ultrasound; Liver biopsy; Liver cirrhosis; Liver disease; Liver fibrosis; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Steatosis

Indexed keywords

DIAGNOSTIC ACCURACY; ECHOGRAPHY; HEPATORENAL ECHOGENICITY; LIVER BIOPSY; LIVER FIBROSIS; MEDICAL PARAMETERS; NONALCOHOLIC FATTY LIVER; POINT OF CARE TESTING; REVIEW; RISK FACTOR; SCREENING; BIOPSY; COMPLICATION; DISEASE COURSE; HOSPITAL INFORMATION SYSTEM; HUMAN; LIVER; LIVER CIRRHOSIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

BIOPSY; DISEASE PROGRESSION; HUMANS; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84902192799     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i22.6821     Document Type: Review

References (26)

1. Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52: 579-585 [PMID: 20185194 DOI: 10.1016/j.jhep.2010.01.008]
2. Chen CH, Lin ST, Yang CC, Yeh YH, Kuo CL, Nien CK. The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C. Dig Dis Sci 2008; 53: 1699-1706 [PMID: 17939048 DOI: 10.1007/s10620-007-0048-2]
3. Baršić N, Lerotić I, Smirčić-Duvnjak L, Tomašić V, Duvnjak M. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18: 3945-3954 [PMID: 22912545 DOI: 10.3748/wjg.v18. i30.3945]
4. Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes 2012; 2012: 483135 [PMID: 23320150]
5. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a metaanalysis. Hepatology 2011; 54: 1082-1090 [PMID: 21618575 DOI: 10.1002/hep.24452]
6. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-1067 [PMID: 19846234 DOI: 10.1016/ j.jhep.2009.09.001]
7. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-2715 [PMID: 17894848 DOI: 10.1111/ j.1572-0241.2007.01526.x]
8. Riley TR, Bruno MA. Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases. J Clin Ultrasound 2005; 33: 439-441 [PMID: 16281268 DOI: 10.1002/jcu.20164]
9. Riley TR, Mendoza A, Bruno MA. Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image. Dig Dis Sci 2006; 51: 982-985 [PMID: 16783524 DOI: 10.1007/s10620-006-9343-6]
10. Riley TR, Kahn A. Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease. Dig Dis Sci 2006; 51: 41-44 [PMID: 16416209 DOI: 10.1007/ s10620-006-3082-6]
11. Kim HC, Choi SH, Shin HW, Cheong JY, Lee KW, Lee HC, Huh KB, Kim DJ. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women. World J Gastroenterol 2005; 11: 5314-5321 [PMID: 16149138]
12. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244 [PMID: 17400323]
13. Grandison GA, Angulo P. Can NASH be diagnosed, graded, and staged noninvasively? Clin Liver Dis 2012; 16: 567-585 [PMID: 22824481]
14. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038]
15. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Ohki T, Yoshida H, Omata M, Makuuchi M, Kokudo N. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation 2009; 88: 575-581 [PMID: 19696642 DOI: 10.1097/TP.0b013e3181b11c19]
16. Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, Scaioli E, Bonato G, Marchesini-Reggiani G, Colecchia A. Review article: the diagnosis of non-alcoholic fatty liver disease--availability and accuracy of noninvasive methods. Aliment Pharmacol Ther 2013; 37: 392-400 [PMID: 23278163 DOI: 10.1111/apt.12186]
17. Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, Repetto G. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14: 635-637 [PMID: 15186630 DOI: 10.1381/09608 9204323093408]
18. Guajardo-Salinas GE, Hilmy A. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Obes Surg 2010; 20: 1647-1653 [PMID: 19957049 DOI: 10.1007/s11695-009-0027-0]
19. de Moura Almeida A, Cotrim HP, Barbosa DB, de Athayde LG, Santos AS, Bitencourt AG, de Freitas LA, Rios A, Alves E. Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound. World J Gastroenterol 2008; 14: 1415-1418 [PMID: 18322958 DOI: 10.3748/wjg.14.1415]
20. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-2717 [PMID: 18042105 DOI: 10.1111/ j.1572-0241.2007.01520.x]
21. Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, Saksouk FA, Wheeler DE, Ehrinpreis MN. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007; 41: 624-629 [PMID: 17577120 DOI: 10.1097/01. mcg.0000225680.45088.01]
22. Ballestri S, Lonardo A, Romagnoli D, Carulli L, Losi L, Day CP, Loria P. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012; 32: 1242-1252 [PMID: 22520641 DOI: 10.1111/j.1478-3231.2012.02804.x]
23. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54, viii [PMID: 17544971 DOI: 10.1016/j.cld.2007.02.014]
24. Lupsor M, Badea R. Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Rom J Gastroenterol 2005; 14: 419-425 [PMID: 16400362]
25. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750 [PMID: 12198701 DOI: 10.1053/gast.2002.35354]
26. Riley TR, Taheri M, Schreibman IR. Does weight history affect fibrosis in the setting of chronic liver disease? J Gastrointestin Liver Dis 2009; 18: 299-302 [PMID: 19795023]